Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3100 Plaza Properties Blvd
Columbus, OH 43219Phone+1 614-383-6000Fax+1 614-383-6001
Education & Training
- University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998
- Cook County Health and Hospitals SystemResidency, Internal Medicine, 1992 - 1995
- Baroda Medical CollegeClass of 1989
Certifications & Licensure
- OH State Medical License 1998 - 2026
- IL State Medical License 1992 - 1999
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 578 citationsPrasugrel versus clopidogrel for acute coronary syndromes without revascularizationMatthew T. Roe, Paul W. Armstrong, Keith A.A. Fox, Harvey D. White, Dorairaj Prabhakaran
The New England Journal of Medicine. 2012-10-03 - 43 citationsProcedural Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions Via the Radial Approach: Insights From an International Chronic Total Occlusion...Peter Tajti, Khaldoon Alaswad, Dimitri Karmpaliotis, Farouc A. Jaffer, Robert W. Yeh
JACC. Cardiovascular Interventions. 2019-02-25 - 29 citationsA Meta-Analysis of Randomized Trials of Rescue Percutaneous Coronary Intervention After Failed FibrinolysisTaral Patel, Anthony A. Bavry, Dharam J. Kumbhani, Stephen G. Ellis
The American Journal of Cardiology. 2006-06-15
Abstracts/Posters
- Bevacizumab (a monoclonal antibody to vascular endothelial growth factor) to prolong progression-free survival in first-line colorectal cancer (CRC) in subjects who ar...Kabbinavar FF, Schulz J, McCleod M, Patel T, Hamm J, Hecht J, Perrou B, Griffing S, Nelson B, Novotny W, ASCO, Multiple Locations, 1/1/2004
- A Single Pegfilgrastim Dose Per Cycle Supports Dose-Dense (q14d) CHOP-R in Patients with NHLMoore T, Patel T, Segal M, Zangmeister J, Chidiac T, Roach R, Thompson M, Larrimer N., Journal of American Society of Hematology – Blood, 11/16/2002
- Second-Line Chemotherapy with Weekly Gemcitabine and Monthly Docetaxel in Patients with Metastatic Breast Cancer: A Phase II StudyLaufman LR, Spiridonidis CH, Carman L, Pritchard J, Roach R, Zangmeister J, Larrimer N, Jones J, Moore T, Segal M, Patel T, Gutterman L, Program/Proceedings of ASCO, Columbus, OH, 1/1/2000
- Join now to see all
Lectures
- Superior Vena Cava Syndrome: An Oncological Emergency1/1/1998
- Polycythemia. Hematology Oncology Lecture Series1/1/1998
- Case presentation of Locally Advanced Pancreatic Cancer Treated with GemcitabineDenver, CO - 1/1/1997
- Join now to see all
Press Mentions
- American Oncology Network Partners with RxLightning to Speed Access to Specialty Medications for Cancer PatientsOctober 5th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: